Diaceutics (DXRX) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Mar 2025 03:00 PM
RNS
PDMR Shareholding/Share Incentive Plan and TVR
31 Jan 2025 09:13 AM
RNS
Purchase of Shares and PDMR Shareholding
30 Jan 2025 11:27 AM
RNS
PDMR Shareholding/Share Incentive Plan
28 Jan 2025 07:00 AM
RNS
FY 2024 Trading Update - Strong Revenue Growth
14 Jan 2025 07:00 AM
RNS
Diaceutics Opens US Headquarters
08 Jan 2025 07:00 AM
RNS
New Service Launched & First Contract Signed
03 Jan 2025 03:39 PM
RNS
PDMR Dealings & Total Voting Rights
19 Dec 2024 08:09 AM
RNS
Holding(s) in Company
17 Dec 2024 10:46 AM
RNS
Holding(s) in Company
17 Dec 2024 07:00 AM
RNS
Diaceutics Wins New $5.1m Contract
10 Dec 2024 03:14 PM
RNS
Holding(s) in Company
05 Dec 2024 07:00 AM
RNS
Awarded UK Research Institute Grant Funding of £1m
03 Dec 2024 02:24 PM
RNS
Total Voting Rights
28 Nov 2024 07:00 AM
RNS
Expansion of US Commercial Activities
05 Nov 2024 07:00 AM
RNS
Capital Markets Webinar
04 Nov 2024 07:00 AM
RNS
Holding(s) in Company
30 Oct 2024 02:58 PM
RNS
PDMR Shareholding/Share Incentive Plan
29 Oct 2024 10:27 AM
RNS
Board Change Update
25 Oct 2024 07:00 AM
RNS
Issue of Share Options/PDMR Shareholdings
24 Oct 2024 12:53 PM
RNS
Cancellation of Share Premium Account
15 Oct 2024 07:00 AM
RNS
Diaceutics Announces Key Leadership Appointment
07 Oct 2024 01:19 PM
RNS
Holding(s) in Company
07 Oct 2024 07:00 AM
RNS
Block Listing Return
02 Oct 2024 07:00 AM
RNS
PDMR Shareholding/Share Incentive Plan
01 Oct 2024 07:00 AM
RNS
Board Changes
17 Sep 2024 07:00 AM
RNS
H1 2024 Results - Continued Performance & Growth
09 Sep 2024 07:00 AM
RNS
Notice of Results & Presentations
02 Sep 2024 07:00 AM
RNS
Appointment of Nominated Adviser and Broker
30 Aug 2024 03:45 PM
RNS
PDMR Shareholding/Share Incentive Plan
27 Aug 2024 07:00 AM
RNS
Diaceutics Launches Enhanced Rare-Disease Offering
19 Aug 2024 07:00 AM
RNS
Enterprise Partnership and Launch of PMx
05 Aug 2024 07:00 AM
RNS
Presenting at Canaccord Genuity Growth Conference
29 Jul 2024 06:09 PM
RNS
PDMR Shareholding/SIP and TVR
29 Jul 2024 07:00 AM
RNS
Issue of Share Options/PDMR Shareholdings
23 Jul 2024 07:05 AM
RNS
Board Changes
23 Jul 2024 07:00 AM
RNS
Revenue growth of 24% in H1 with 55% now recurring
11 Jul 2024 07:00 AM
RNS
Senior Management Appointments
01 Jul 2024 07:00 AM
RNS
PDMR Shareholding/SIP and Total Voting Rights
24 Jun 2024 01:15 PM
RNS
Result of AGM
13 Jun 2024 07:00 AM
RNS
"Precision Medicine in Oncology " Virtual Event
06 Jun 2024 07:00 AM
RNS
Diaceutics - Capital Markets Event
29 May 2024 08:00 AM
RNS
Notice of AGM and Posting of Annual Report
29 May 2024 08:00 AM
RNS
Notice of AGM and Posting of Annual Report
28 May 2024 07:00 AM
RNS
Data to be Presented at 2024 ASCO Annual Meeting
24 May 2024 03:01 PM
RNS
PDMR Shareholding/SIP and Total Voting Rights
23 May 2024 07:00 AM
RNS
Director / PDMR Shareholding
21 May 2024 07:00 AM
RNS
Revenue growth of 22% & order book growth of 57%
16 May 2024 07:00 AM
RNS
Two New Enterprise-Wide Engagements
14 May 2024 07:00 AM
RNS
Diaceutics - Capital Markets Event
01 May 2024 07:00 AM
RNS
Notice of Results & Presentations

Diaceutics is a technology and data analytics company focused on precision medicine. Headquartered in Belfast, the company provides data, software, and advisory services that help pharmaceutical and biotechnology companies improve the adoption of diagnostic testing and support the commercialisation of precision therapies. Its platform integrates real-world diagnostic data from a global network of laboratories to provide insights into testing and treatment pathways.

Diaceutics share price is listed in London under the ticker DXRX.

UK 100